株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

ビタミンD検査の世界市場:2015年〜2019年

Global Vitamin D Testing Market 2015-2019

発行 TechNavio (Infiniti Research Ltd.) 商品コード 229565
出版日 ページ情報 英文 72 Pages
即納可能
価格
本日の銀行送金レート: 1USD=114.71円で換算しております。
Back to Top
ビタミンD検査の世界市場:2015年〜2019年 Global Vitamin D Testing Market 2015-2019
出版日: 2015年07月22日 ページ情報: 英文 72 Pages
概要

世界のビタミンD検査市場は、2014年から2019年の間、7.57%のCAGRで拡大することが見込まれています。

当レポートでは、世界のビタミンD検査市場について調査しており、市場の規模とその予測、市場の成長要因や課題、主要ベンダーの分析などの情報をまとめています。

第1章 エグゼクティブサマリー

第2章 略語リスト

第3章 調査範囲

  • 市場概要
  • 主な製品

第4章 市場調査手法

  • 市場調査プロセス
  • 調査手法

第5章 イントロダクション

第6章 市場情勢

  • 市場概要
  • 市場規模と予測
  • ファイブフォース分析

第7章 検査タイプ別の市場分類

  • 25-ヒドロキシビタミンD検査
  • 1,25-ヒドロキシビタミンD検査

第8章 検査方法タイプ別の市場分類

  • 免疫学的検定 (イムノアッセイ)
  • 直接検出

第9章 エンドユーザー別の市場分類

  • 世界のビタミンD検査市場:エンドユーザー別

第10章 地理区分

  • 世界のビタミンD検査市場:地域別
  • 南北アメリカ
    • 市場規模と予測
  • 欧州・中東・アフリカ地域
    • 市場規模と予測
  • アジア太平洋地域
    • 市場規模と予測

第11章 購入基準

第12章 市場成長因子

第13章 成長因子とその影響

第14章 市場の課題

第15章 成長因子と課題の影響

第16章 市場動向

第17章 動向とその影響

第18章 ベンダー情勢

  • 競合シナリオ
    • 主なニュース
    • M&A
  • 市場シェア分析
  • その他の有力ベンダー

第19章 主要ベンダーの分析

  • Abbott Diagnostics
  • DiaSorin
  • bioMeriux
  • Siemens Healthcare Diagnostics
  • Roche Diagnostics

第20章 関連レポート

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: IRTNTR6510

About Vitamin D Testing

Vitamin D is a naturally occurring, fat-soluble, biologically inert hormone precursor that exists in two primary forms: vitamin D2 (ergocalciferol) and vitamin D3 (cholecalciferol). Its main biologic function is to maintain calcium and phosphorus concentrations as it is essential for the overall bone health. Vitamin D has a number of other physiological roles, including retaining muscle strength, moderating immune function, regulating cellular differentiation, and reducing inflammation. Vitamin D test, also called 25-Hydroxy test, is used to measure the amount of vitamin in the bloodstream to rule out vitamin D deficiency. It can help determine the bone weakness, bone malformation, or abnormal metabolism of calcium (reflected by abnormal calcium, phosphorus, and PTH levels) as a result of a deficiency or excess of vitamin D.

Technavio's analysts forecast the global vitamin D testing market to grow at a CAGR of 7.57% during the period 2014-2019.

Covered in this Report

The report covers the present scenario and the growth prospects of the global vitamin D testing market for the period 2015-2019. To calculate the market size, the report considers revenue generated through vitamin D tests.

Technavio's report, Global Vitamin D Testing Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers Americas, APAC, and EMEA; it also covers the market landscape and its growth prospects over the coming years.

The report includes a discussion of the key vendors operating in this market.

Key Geographies

  • Americas
  • APAC
  • EMEA

Key Vendors

  • Abbott
  • BioMerieux
  • Diasorin
  • F. Hoffmann-La Roche
  • Siemens

Other Prominent Vendors

  • DIAsource ImmunoAssays
  • Gold Standard Diagnostics
  • Immunodiagnostic Systems Holdings
  • Ortho Clinical Diagnostics Inc.
  • Qualigen
  • Quest Diagnostics
  • Tosoh Bioscience

Market Driver

  • Ageing Population and Chronic Diseases
  • For a full, detailed list, view our report

Market Challenge

  • Declining Prices in Developed Countries
  • For a full, detailed list, view our report

Market Trend

  • Introduction of Novel Technology
  • For a full, detailed list, view our report

Key Questions Answered in this Report

  • What will the market size be in 2019 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

  • 03.1. Market Overview
  • 03.2. Product Offerings

04. Market Research Methodology

  • 04.1. Market Research Process
  • 04.2. Research Methodology

05. Introduction

06. Market Landscape

  • 06.1. Market Overview
  • 06.2. Market Size and Forecast
  • 06.3. Five Forces Analysis

07. Market Segmentation by Type of Test

    • 07.1.1. 25-Hydroxy Vitamin D Test
    • 07.1.2. 1,25-Hydroxy Vitamin D Test

08. Market Segmentation by Type of Method

    • 08.1.1. Immunoassays
    • 08.1.2. Direct Detection Methods

09. Market Segmentation by End-user

  • 09.1. Global Vitamin D Testing Market by End-user

10. Geographical Segmentation

  • 10.1. Global Vitamin D Testing Market by Geographical Segmentation 2014-2019
  • 10.2. Vitamin D Testing Market in Americas
    • 10.2.1. Market Size and Forecast
  • 10.3. Vitamin D Testing Market in EMEA
    • 10.3.1. Market Size and Forecast
  • 10.4. Vitamin D Testing Market in APAC
    • 10.4.1. Market Size and Forecast

11. Buying Criteria

12. Market Growth Drivers

13. Drivers and their Impact

14. Market Challenges

15. Impact of Drivers and Challenges

16. Market Trends

17. Trends and their Impact

18. Vendor Landscape

  • 18.1. Competitive Scenario
    • 18.1.1. Key News
    • 18.1.2. Mergers and Acquisitions
  • 18.2. Market Share Analysis 2014
  • 18.3. Other Prominent Vendors

19. Key Vendor Analysis

  • 19.1. Abbott Diagnostics
    • 19.1.1. Key Facts
    • 19.1.2. Business Overview
    • 19.1.3. Geographical Presence
    • 19.1.4. SWOT Analysis
  • 19.2. DiaSorin
    • 19.2.1. Key Facts
    • 19.2.2. Business Overview
    • 19.2.3. Business Segmentation by Revenue 2013
    • 19.2.4. Business Segmentation by Revenue 2012 and 2013
    • 19.2.5. Geographical Segmentation by Revenue 2013
    • 19.2.6. Business Strategy
    • 19.2.7. Recent Developments
    • 19.2.8. SWOT Analysis
  • 19.3. bioMeriux
    • 19.3.1. Key Facts
    • 19.3.2. Business Overview
    • 19.3.3. Business Segmentation by Revenue 2013
    • 19.3.4. Geographical Segmentation by Revenue 2013
    • 19.3.5. Business Strategy
    • 19.3.6. Recent Developments
    • 19.3.7. SWOT Analysis
  • 19.4. Siemens Healthcare Diagnostics
    • 19.4.1. Key Facts
    • 19.4.2. Business Overview
    • 19.4.3. SWOT Analysis
  • 19.5. Roche Diagnostics
    • 19.5.1. Key Facts
    • 19.5.2. Business Overview
    • 19.5.3. Business Segmentation by Revenue 2014
    • 19.5.4. Business Segmentation by Revenue 2013 and 2014
    • 19.5.5. Geographical Segmentation by Revenue 2014
    • 19.5.6. Business Strategy
    • 19.5.7. Recent Developments
    • 19.5.8. SWOT Analysis

20. Other Reports in this Series

List of Exhibits

  • Exhibit 1: Market Research Methodology
  • Exhibit 2: Global Vitamin D Testing Market 2015-2019 ($ millions)
  • Exhibit 3: Consequences of Vitamin D Deficiency
  • Exhibit 4: Global Guidelines for Vitamin D Test Range
  • Exhibit 5: Recommended Daily Intakes of Vitamin D for Global Population
  • Exhibit 6: Upper Limits of Vitamin D Intakes for Global Population
  • Exhibit 7: Segmentation of Global Vitamin D Testing Market by Type of Test
  • Exhibit 8: Segmentation of Global Vitamin D Testing Market by Type
  • Exhibit 9: Segmentation of Global Vitamin D Testing Market by Type of Method
  • Exhibit 10: Segmentation of Global Vitamin D Testing Market by End-user
  • Exhibit 11: Segmentation of Global Vitamin D Testing Market by End-user 2014
  • Exhibit 12: Vitamin D Market in Americas 2014-2019 ($ millions)
  • Exhibit 13: Vitamin D Market in US by Volume 2014-2019 (million units)
  • Exhibit 14: Vitamin D Market in EMEA by Revenue 2014-2019 ($ millions)
  • Exhibit 15: Vitamin D Market in EMEA by Volume 2014-2019 (million units)
  • Exhibit 16: Vitamin D Market in APAC by Revenue 2014-2019 ($ millions)
  • Exhibit 17: Abbott Diagnostics: Key Takeaways
  • Exhibit 18: bioMerieux: Key Takeaways
  • Exhibit 19: DiaSorin: Key Takeaways
  • Exhibit 20: Siemens: Key Takeaways
  • Exhibit 21: Roche Diagnostics: Key Takeaways
  • Exhibit 22: Abbott Diagnostics: Geographical Presence
  • Exhibit 23: DiaSorin: Business Segmentation by Revenue 2013
  • Exhibit 24: DiaSorin: Business Segmentation by Revenue 2012 and 2013 (US$ million)
  • Exhibit 25: DiaSorin: Geographical Segmentation by Revenue 2013
  • Exhibit 26: bioMeriux: Business Segmentation by Revenue 2013
  • Exhibit 27: bioMeriux: Geographical Segmentation by Revenue 2013
  • Exhibit 28: Roche Diagnostics: Business Segmentation by Revenue 2014
  • Exhibit 29: Roche Diagnostics: Business Segmentation by Revenue 2013 and 2014 ($ billion)
  • Exhibit 30: Roche Diagnostics: Geographical Segmentation by Revenue 2014
Back to Top